A warm welcome to Allison Rossiter

Genetic Signatures’ CEO, Allison Rossiter, brings a distinguished career in healthcare. With a proven track record at Roche Diagnostics, she navigated complex strategic challenges to achieve notable success. Ms Rossiter’s vision and leadership will be invaluable to Genetic Signatures as we enter our next phase of growth. She is warmly welcomed by the team!

Allison began her career in Pfizer’s IT department while completing a degree in Computing & Informatics, and a dissertation on the electronic data capture for clinical trials. After graduating, she worked as a network engineer for the Canadian telecoms giant Nortel Networks, laying the foundation for her IT career. Seizing the opportunity for change and challenge, Allison pivoted to a completely new role as Territory Sales Manager at Roche in the UK—a career-defining move. Allison’s transition to Roche was immediately impactful. Her desire to make a difference,

combined with exceptional communication skills, enabled her to forge strong client relationships and exceed sales targets year after year. Allison’s natural aptitude for leadership saw her rise to various senior roles within Roche UK, where she built and delivered robust strategies to lead her team to success. As Director of Point of Care Diagnostics for the UK and Ireland, she notably secured government reimbursement for diagnostic tests, directly writing to the Prime Minister to lobby for assistance – a bold and successful initiative that underscored her determination and leadership.

Her career continued in Canada as the Executive Director of Sales, leading the Company to repeatedly exceed both revenue and profit targets for the first time in over a decade, and later in the US, as Life Cycle leader, Point of Care Molecular, delivering a strategy that propelled global growth in a rapidly emerging diagnostic segment. After taking the product from start up to scale up, Allison jumped at the opportunity to lead Roche Diagnostics Australia as Managing Director, navigating change management to transform the culture and support a more agile and customer centric organisation. In this role, Allison faced significant leadership challenges created by the COVID-19 pandemic, ultimately steering the team to success.

“All the experiences in my career to this point gave me the training to deal with this crisis. Remaining calm under pressure was essential. The experience has shaped me as a person and a leader.”

After five years at the helm, Allison now embraces her role as CEO at Genetic Signatures, where she aims to advance the Company’s patented 3base® technology for the detection of infectious disease, and expand Genetic Signatures’ impact on the global stage.

“Supporting an Australian company to become an international success would be hugely rewarding. It would give me immense pride to make a difference of this scale. I thrive on these challenges! I am so excited as the Company is just opening up to the US and we are nimble and agile enough to make real, positive change to drive growth, and change the lives of patients. I am also honoured to break further boundaries for more female CEOs within this industry.”

To support Genetic Signatures’ growth, Allison emphasises the importance of resilience, a clear strategic vision, focus, and the courage to take measured risks.

“Fortune favours the bold. I believe in creating and executing a shared strategy with clearly defined goals that pave the way to success. I want Genetic Signatures to thrive, and for my team to be the best versions of themselves. I take pride in my team’s efforts and celebrating their achievements is something I truly cherish.”